Homeopathic Vaccine Trial
NCT02825368 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2017-08-04
Summary
The purpose of the study is to compare the immunological response of homeopathic vaccines to placebo and to conventional vaccines in healthy young adults.
Conditions
- Healthy Volunteers
Interventions
- OTHER
-
Tetanotxicum®
- BIOLOGICAL
-
MMR
0.5 mL, subcutaneous
- BIOLOGICAL
-
Tdap
0.5 mL, intramuscular
- OTHER
-
Diphtherinum®
- OTHER
-
Pertussinum®
- OTHER
-
Morbilinum®
- OTHER
-
Ourlianum®
- OTHER
-
Sterile saline
0.5 mL, intramuscular
- OTHER
-
Sugar pellets
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2017-08-31
Countries
- Canada
Study Locations
More Related Trials
-
Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
NCT04099303 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
NCT01529645 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis
NCT02040636 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)
NCT06708286 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Pertussis Vaccine in Healthy Pregnant Women
NCT00707148 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
NCT00263679 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection
NCT06903221 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents
NCT01629589 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
NCT05951725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
NCT06056050 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
NCT06857370 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine
NCT00452686 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
NCT00610168 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
NCT06344065 ·Status: RECRUITING ·Phase: PHASE3
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease
NCT00282295 ·Status: COMPLETED ·Phase: PHASE4
-
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
NCT00802867 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.
NCT00406562 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
NCT00297856 ·Status: COMPLETED
-
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
NCT00777257 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children
NCT05870618 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
NCT05091619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
NCT00258882 ·Status: COMPLETED
-
Adacel® Booster Vaccination for CMI Assay Development
NCT04543669 ·Status: COMPLETED ·Phase: PHASE4